 Hey guys, this is Rich from Rich TV Live and Tilray is having a day up 7.54%. Now the question is why. You can read right here it says Tilray shares surge on Novartis distribution deal. Let's read the news. Tilray extends Sandoz Canadian cannabis pharmaceutical collaboration globally. Tilray Canada limited a subsidiary of Tilray Inc, a global pioneer in the production research and distribution of medical cannabis announced today it has entered into a global framework agreement to collaborate with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars and a part of Novara's group to increase availability of high quality medical cannabis products around the world. Huge news. An evolution of an existing alliance between Tilray and Sandoz Canada, the framework agreement represents the intentions of the two companies to jointly operate in jurisdictions where cannabis is or will be approved for medical purposes. Tilray, a global pioneer of medical cannabis, has products available in 12 countries and operations in Australia, New Zealand, Canada, Germany, Latin America and Portugal. The agreements builds on Tilray's pioneering track record as a company committed to making pharmaceutical grade medical cannabis products available to patients in need. Tilray was the first licensed medical cannabis producer in North America to obtain current good manufacturing practice, otherwise known as CGMP certification in accordance with the European Medicines Agency EMA standards. This agreement represents a major milestone in the movement to provide access to safe GMP certified medical cannabis to patients in need across the world. Tilray is a global company and we're thrilled to build upon the success and momentum from our existing agreement with Sandoz Canada by taking our partnership global. Sandoz AG will be a valuable partner as we work together to improve access to the highest quality medical cannabis products in Canada and countries all over the world. This is Brendan Kennedy, Tilray Chief Executive Officer. The framework agreement outlines the opportunity for the companies to collaborate in different forms. Sandoz AG may support the global commercialization of Tilray's non-smokable, non-combustible medical cannabis products. Tilray and Sandoz AG may co-brand certain non-smokable, non-combustible products. Tilray may supply non-smokable, non-combustible medical cannabis products and license rights from Sandoz AG in relation to such products. Both companies may also partner to leverage best in-class knowledge to educate pharmacists and physicians about medical cannabis products. Tilray and Sandoz AG may collaborate to develop new innovative medical cannabis products about Tilray. Tilray is a global pioneer in the research cultivation production and distribution of medical cannabis and cannabinoids currently serving tens of thousands of patients in 12 countries spanning five continents. What do you think about this news? Clearly, it is affecting the market and Tilray has had a big day. They've been up as much as 10%. They've come back a little bit. They are now up 8.65%. Now, remember, Rich TV Live is strictly for education and entertainment purposes. Always do your due diligence. Always do your research before you invest in anything that we talk about here at Rich TV Live. Get all the breaking news, top stock tools we use, cryptocurrencies. You want to contact us? You want to follow us on all social media? Hover over contact? It's all right there. Now remember, if you're not winning, you're most likely not watching. We bring in the winners, we bring in the news, and we bring it to you first. We are one week away from Christmas. I wish you all a happy holidays with your friends and family. I love you guys. Thank you for all your support. This is your boy, Rich, bringing you Tilray Inc. up 8.65% on this big news. Comment down below, smash the like button, share the video everywhere. I want to know what you think about Tilray. Is it a bye? This is your boy, Rich, and I'm out. Peace.